Elanco Animal Health (ELAN) Other Non-Current Assets (2017 - 2026)

Elanco Animal Health (ELAN) reported Other Non-Current Assets of $295.0 million for Q1 2026, down 5.45% on a YoY basis from $312.0 million in Q1 2025, and down 2.96% sequentially from $304.0 million in Q4 2025.

Elanco Animal Health (ELAN) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Elanco Animal Health (ELAN) has 10 years of Other Non-Current Assets data on file, last reported at $295.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets fell 5.45% year-over-year to $295.0 million; the trailing twelve-month figure through Mar 2026 stood at $295.0 million (down 5.45% YoY), and the FY2025 full-year result was $304.0 million, down 2.25% from the prior year.
  • Other Non-Current Assets fell to $295.0 million in Q1 2026, from $304.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $559.0 million in Q1 2022 to a low of $295.0 million in Q1 2026.
  • A 5-year average of $355.1 million and a median of $341.0 million in 2023 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets jumped 72.0% in 2022 and slumped 33.99% in 2023, its largest moves.
  • Tracing ELAN's Other Non-Current Assets over 5 years: stood at $378.0 million in 2022, then retreated by 9.79% to $341.0 million in 2023, then decreased by 8.8% to $311.0 million in 2024, then dropped by 2.25% to $304.0 million in 2025, then decreased by 2.96% to $295.0 million in 2026.
  • Business Quant data shows ELAN's Other Non-Current Assets at $295.0 million in Q1 2026, $304.0 million in Q4 2025, and $306.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 4.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 295.00 Mn
Dec 31, 2025 304.00 Mn
Sep 30, 2025 306.00 Mn
Jun 30, 2025 308.00 Mn
Mar 31, 2025 312.00 Mn
Dec 31, 2024 311.00 Mn
Sep 30, 2024 302.00 Mn
Jun 30, 2024 324.00 Mn
Mar 31, 2024 346.00 Mn
Dec 31, 2023 341.00 Mn
Sep 30, 2023 410.00 Mn
Jun 30, 2023 419.00 Mn
Mar 31, 2023 369.00 Mn
Dec 31, 2022 378.00 Mn
Sep 30, 2022 376.00 Mn
Jun 30, 2022 376.00 Mn
Mar 31, 2022 559.00 Mn
Dec 31, 2021 390.00 Mn
Sep 30, 2021 357.00 Mn
Jun 30, 2021 375.00 Mn